adenovirus vaccine

（原始内容存档于2020-10-14）.  Phase IIb Clinical Trial of A COVID-19 Vaccine Named Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) - Full Text View - ClinicalTrials

PMID 9469800. doi:10.1126/science.279.5354.1173.  A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA. The New England Journal of Medicine. 2016-04-28

Jun-Jie. Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised

Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human

DelNS1-2019-nCoV-RBD-OPT Serum Institute starts manufacturing Codagenix's nasal COVID-19 vaccine. mint. 22 September 2020 [2021-06-16]. （原始内容存档于2021-03-03） （英语）.  COVI-VAC